Bio Sequence

Locating Sequence Hits in Patents Has Never Been Easier!

5 January 2024
2 min read

Difficulty: Users experience complications when locating the target sequence patents in the Patsnap Bio Sequence Database. After finding such a patent, they need to delve into the patent details to identify both the location and description of the target sequence specified therein.

Solution: We've developed a feature to make it easier for users to Drastically cut down patent review times by focusing on the most relevant claim. Drug patent searches now allow you to identify the exact claim location of your hit sequences and the accompanying claim text directly from the results page!

Location data of hit sequence in claims

Three new fields were added to the search results:

  1. Hit Sequence (In Claim): Sequence number and SEQ ID of hit sequence in claims.
  2. Hit Sequence Location (In Claim): Specific claim number in which the hit sequence is located.
  3. Hit Sequence Text (In Claim): The claim text in which the hit sequence is referenced.

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated, illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is available for the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

Bristol Myers Squibb Expands Portfolio with Purchase of Leading Radiopharmaceutical Company RayzeBio
Latest Hotspot
3 min read
Bristol Myers Squibb Expands Portfolio with Purchase of Leading Radiopharmaceutical Company RayzeBio
2 January 2024
RayzeBio's RYZ101 targets SSTR2, often overexpressed in GEP-NETs and extensive stage small cell lung cancer.
Read →
Exploring TLR agonists: What They Are and How to Keep Up with the Latest Advances
Exploring TLR agonists: What They Are and How to Keep Up with the Latest Advances
2 January 2024
TLR agonists are substances that activate the Toll-like receptor, enhancing the immune response against pathogens.
Read →
Coherus announces FDA approval for UDENYCA ONBODY™, a cutting-edge pegfilgrastim-cbqv delivery technology
Latest Hotspot
3 min read
Coherus announces FDA approval for UDENYCA ONBODY™, a cutting-edge pegfilgrastim-cbqv delivery technology
2 January 2024
Coherus has revealed that UDENYCA ONBODY™, an innovative and advanced technology for administering pegfilgrastim-cbqv, has received authorization from the FDA.
Read →
What are the types of protein sulfation and their implications in protein-protein interactions?
"What" Series
2 min read
What are the types of protein sulfation and their implications in protein-protein interactions?
2 January 2024
Protein sulfation is a post-translational modification, where a sulfate group gets added to a specific amino acid residue in a protein.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.